CTOs on the Move

Dallas Museum of Art

www.dma.org

 
Located in the vibrant Arts District of downtown Dallas, Texas, the Dallas Museum of Art (DMA) ranks among the leading art institutions in the country and is distinguished by its innovative exhibitions and ground breaking educational programs. At the heart of the Museum and its programs are its comprehensive collections, which encompass more than 24,000 works and span 5,000 years of history, representing a full range of world cultures. The DMA`s collections are distinguished in many areas: its contemporary collection is one of the top ten most important of any comprehensive museum in the U.S., and its collection of art ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.dma.org
  • 1717 North Harwood
    Dallas, TX USA 75201
  • Phone: 214.922.1200

Executives

Name Title Contact Details
Amir Tabei
Chief Information Officer Profile

Similar Companies

Information Specialists Group

Information Specialists Group is a Minneapolis, MN-based company in the Business Services sector.

HomeStart

HomeStarts Mission - To end homelessness in Greater Boston by assisting individuals in obtaining housing and settling into the community, and by developing strategies to prevent homelessness before it starts.​

Jaco Sales Inc

Jaco Sales Inc is a Little Rock, AR-based company in the Business Services sector.

Tolleson Design

Tolleson Design is a San Francisco, CA-based company in the Business Services sector.

Anterios

Anterios is a privately held, clinical-stage biopharmaceutical company that is developing next-generation botulinum-based prescription products for medical dermatology and aesthetic medicine. Anterios has developed NDSTM, a proprietary platform technology that enables local, targeted delivery of botulinum toxin and other macromolecules across the skin without needles or other invasive treatments that can be destructive to the skin. NDS also enables the formulation of macromolecules as ready-to-use liquid injectable products. In the future, Anterios plans to develop additional dermatology products to topically deliver active ingredients other than botulinum, as well as formulate additional injectable products that require deeper delivery.